Intersectional Stigma Reduction for Tajik Migrants Who Inject Drugs

减少注射毒品的塔吉克移民的跨部门耻辱

基本信息

  • 批准号:
    10755435
  • 负责人:
  • 金额:
    $ 17.81万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-08-04 至 2026-03-31
  • 项目状态:
    未结题

项目摘要

Project Summary Labor migration is a major contributor to fueling the global AIDS epidemic and also the movement of HIV across country borders and populations. Migrants who inject drugs while in a host country are at especially high risk. Tajikistan, a small country in Central Asia, exports more than a million temporary labor migrants annually, many of whom inject drugs. These migrants are highly subject to the negative effects of intersectional stigma within Russia's cultural and socio-economic environment due to being both a migrant worker and a person who injects drugs (PWID). In addition, they are subject to extensive censure and marginalization from their non-drug-using Tajik peers in the close-knit diaspora communities in which they reside, especially if they acquire HIV. The adverse effects of stigmatization on those who experience it are well documented. The intersection of stigmatized identities as migrants and people who inject drugs (PWID), along with stigma associated with HIV infection, contributes to HIV risk behavior, poses as a barrier to accessing HIV testing and other prevention/treatment services, and results in poorer health outcomes for those living with HIV. The proposed study will investigate the character of stigma in the Moscow Tajik migrant community, and the effects of multiple intersecting forms of stigma on the health and well-being of Tajik labor migrants who inject drugs while living in Moscow (Aim 1). We will use the insight and findings gained through this formative research to develop an innovative intervention specifically designed to counter the negative effects of drug- related stigma within the Tajik migrant community that can affect HIV risk behavior and prevention among Tajik migrants in Moscow who inject drugs (Aim 2). The Stigma Reduction Intervention Approach Via Leaders of Diaspora (SRI-AVLOD) intervention will draw on the strengths of close-knit Tajik diaspora communities in which new norms and behaviors can be effectively diffused and promoted within and across migrant social networks if endorsed by leaders whom they trust. SRI-AVLOD is designed to recruit and train Tajik diaspora community leaders as agents of change and open up conversation within the Moscow Tajik community about the effects of drug and HIV-related stigma, to reduce stigmatizing beliefs and actions that negatively affect HIV risk behavior and prevention among community members who inject drugs. After developing a working prototype, we will deliver the intervention to small groups of Tajik migrant community leaders to assess its feasibility and acceptability, and need for further modifications (Aim 3). In future work we will deliver and test the efficacy of the SRI-AVLOD model in changing drug-related stigma and stigmatizing beliefs, behavior, and consequences at all levels (community, leadership, PWID) within the Tajik diaspora community and its positive effects in reducing HIV risk behavior and increasing the adoption of HIV prevention methods and services among its Tajik members who inject drugs.
项目概要 劳务移民是助长全球艾滋病流行和艾滋病毒传播的主要因素 跨越国界和人口。在东道国注射吸毒的移民尤其容易受到伤害 高风险。中亚小国塔吉克斯坦输出超百万临时劳务移民 每年,其中许多人注射毒品。这些移民很容易受到跨部门的负面影响 由于既是移民工人又是俄罗斯人,在俄罗斯的文化和社会经济环境中蒙受耻辱。 注射毒品者 (PWID)。此外,他们还受到广泛的谴责和边缘化。 他们居住的紧密的侨民社区中不吸毒的塔吉克同龄人,特别是如果他们 感染艾滋病毒。污名化对遭受污名化的人造成的不利影响是有据可查的。这 移民和注射吸毒者 (PWID) 等污名化身份的交集,以及耻辱感 与 HIV 感染相关,导致 HIV 危险行为,成为获得 HIV 检测的障碍, 其他预防/治疗服务,并导致艾滋病毒感染者的健康状况较差。 拟议的研究将调查莫斯科塔吉克移民社区的耻辱特征, 以及多种交叉形式的耻辱对塔吉克斯坦劳工移民的健康和福祉的影响 在莫斯科居住期间注射毒品(目标 1)。我们将利用通过这一形成性过程获得的见解和发现 研究开发一种创新干预措施,专门用于对抗药物的负面影响 塔吉克移民社区内的相关耻辱可能会影响塔吉克人的艾滋病毒危险行为和预防 莫斯科注射毒品的移民(目标 2)。通过领导人的减少耻辱干预方法 侨民 (SRI-AVLOD) 干预措施将利用塔吉克斯坦侨民社区联系紧密的优势 哪些新的规范和行为可以在移民社会内部和之间有效地传播和推广 网络如果得到他们信任的领导人的认可。 SRI-AVLOD 旨在招募和培训塔吉克侨民 社区领袖作为变革的推动者,并在莫斯科塔吉克社区内展开对话 毒品和艾滋病毒相关耻辱的影响,以减少对艾滋病毒产生负面影响的耻辱信念和行为 注射吸毒社区成员的风险行为和预防。开发出工作后 原型,我们将向塔吉克移民社区领导人小组提供干预措施,以评估其 可行性和可接受性,以及进一步修改的必要性(目标 3)。 在未来的工作中,我们将交付并测试 SRI-AVLOD 模型在改变药物相关性方面的功效。 各个层面(社区、领导层、吸毒者)的耻辱和污名化信念、行为和后果 塔吉克斯坦侨民社区及其在减少艾滋病毒危险行为和增加艾滋病毒感染率方面的积极影响 在注射吸毒的塔吉克族成员中采用艾滋病毒预防方法和服务。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Mahbat Bahromov其他文献

Mahbat Bahromov的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Mahbat Bahromov', 18)}}的其他基金

Scaling-Up Stepped Care for Women's Mental Health in Primary Care in an LMIC
在中低收入国家的初级保健中扩大对妇女心理健康的分级护理
  • 批准号:
    10477040
  • 财政年份:
    2019
  • 资助金额:
    $ 17.81万
  • 项目类别:
Scaling-Up Stepped Care for Women's Mental Health in Primary Care in an LMIC
在中低收入国家的初级保健中扩大对妇女心理健康的分级护理
  • 批准号:
    10247042
  • 财政年份:
    2019
  • 资助金额:
    $ 17.81万
  • 项目类别:
Scaling-Up Stepped Care for Women's Mental Health in Primary Care in an LMIC
在中低收入国家的初级保健中扩大对妇女心理健康的分级护理
  • 批准号:
    10676331
  • 财政年份:
    2019
  • 资助金额:
    $ 17.81万
  • 项目类别:
Scaling-Up Stepped Care for Women's Mental Health in Primary Care in an LMIC
在中低收入国家的初级保健中扩大对妇女心理健康的分级护理
  • 批准号:
    10001626
  • 财政年份:
    2019
  • 资助金额:
    $ 17.81万
  • 项目类别:

相似海外基金

RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    10219039
  • 财政年份:
    2020
  • 资助金额:
    $ 17.81万
  • 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    9981476
  • 财政年份:
    2019
  • 资助金额:
    $ 17.81万
  • 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    9364184
  • 财政年份:
    2016
  • 资助金额:
    $ 17.81万
  • 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
  • 批准号:
    236932
  • 财政年份:
    2011
  • 资助金额:
    $ 17.81万
  • 项目类别:
    Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
  • 批准号:
    3554155
  • 财政年份:
    1991
  • 资助金额:
    $ 17.81万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6766860
  • 财政年份:
    1991
  • 资助金额:
    $ 17.81万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6256640
  • 财政年份:
    1991
  • 资助金额:
    $ 17.81万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
  • 批准号:
    3554156
  • 财政年份:
    1991
  • 资助金额:
    $ 17.81万
  • 项目类别:
Studies on cofactors for development of acquired immunodeficiency syndrome in feline immunodeficiency virus infection.
猫免疫缺陷病毒感染后获得性免疫缺陷综合征发生的辅助因子研究。
  • 批准号:
    03660315
  • 财政年份:
    1991
  • 资助金额:
    $ 17.81万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
  • 批准号:
    2063342
  • 财政年份:
    1991
  • 资助金额:
    $ 17.81万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了